1 / 8

Nabil-Lally-Highlights-Real-Time-Clinical-Data-at-DCAT-2025

At DCAT Week 2025 in New York City, Nabil Lally, Senior Director of Business Development at Quotient Sciences, shared key insights on how real-time clinical data can bring speed and certainty to formulation development.<br><br>linkedin.com/in/nabillally

Nabil38
Download Presentation

Nabil-Lally-Highlights-Real-Time-Clinical-Data-at-DCAT-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nabil Lally Highlights Real-Time Clinical Data at DCAT 2025 Nabil Lally from Quotient Sciences presented at DCAT Week 2025 on leveraging real-time clinical data to revolutionize formulation development. Discover how the Translational Pharmaceutics platform is transforming early-phase drug development.

  2. The Challenge: Traditional Drug Development Bottlenecks Traditional drug development often follows a rigid, sequential path, leading to significant delays and increased costs. This linear approach can hinder progress and extend the time it takes for essential medicines to reach patients. Sequential Phases Delayed Feedback High Failure Rates Distinct, isolated stages from discovery to clinical trials. Insights from clinical data are often gathered only after phase completion. Inability to adapt formulations mid-study increases risks.

  3. Quotient's Translational Pharmaceutics Platform Quotient Sciences' innovative platform integrates drug product manufacturing and clinical testing, enabling real-time adjustments and accelerating development. Integrated Approach Combines formulation, manufacturing, and clinical trials. Real-Time Data Immediate insights on drug absorption and patient response. Adaptive Design Allows for mid-study formulation adjustments.

  4. Unlocking Speed and Certainty Nabil Lally highlighted how real-time clinical data provides unprecedented speed and certainty in drug formulation. Accelerated Timelines Reduced Costs Improved Decision-Making Optimizes resource allocation by minimizing study iterations. Compresses development by 6-12 months, bringing drugs to market faster. Data-driven insights enable agile adjustments and reduce failure risks.

  5. Proven Success: Case Studies With over 300 successful programs, Quotient Sciences has demonstrated the profound impact of their approach. Pediatric Dosage Accurate dosage adjustments for a pediatric drug based on real-time patient data. Oncology Breakthrough Optimal formulation for a cancer drug identified within a single clinical study. Broad Application Applicable across various therapeutic areas, from small molecules to biologics.

  6. Regulatory Acceptance and Fast Tracks The paradigm shift towards real-time data is gaining traction with regulatory bodies, facilitating faster submissions and approvals. Streamlined Submissions Real-time data supports fast-track designations like Breakthrough Therapy and Fast Track. Regulatory agencies are increasingly amenable to mid-study changes when rigorously documented with immediate data.

  7. Key Takeaways from DCAT 2025 Nabil Lally's presentation underscored the transformative potential of integrating real-time data into drug development. Accelerated Timelines Data-Driven Precision Strategic Advantage Significant reduction in development duration. Enhanced formulation accuracy with immediate feedback. Positioning for faster regulatory pathways.

  8. Driving the Future of Drug Development Quotient Sciences continues to lead the way in early-phase drug development, promising a future of faster, more efficient, and more certain drug delivery.

More Related